cancer research

Juno Theraputics

Seattle-based scientists are reporting more encouraging results from treating blood cancer patients with souped-up immune cells.

The trial, part of a larger study by Seattle-based biotechnology Juno Therapeutics, involved about 50 people with three different types of blood cancer. Patients in this type of trial typically have not responded to the usual treatments, and are nearly out of options.

Scientists from Fred Hutchinson Cancer Research Center re-engineered the patients’ immune cells and injected them back into their bodies. Dr. Cameron Turtle of Fred Hutch reported Monday that 91 percent of those with acute lymphoblastic leukemia went into remission.

Gerry Broome / AP Photo

For someone with cancer who lives far from a big city, it can be hard to access cutting-edge care, but a network of Northwest hospitals is getting millions to bring clinical cancer trials to far-flung communities.

Clinical trials study experimental drugs and therapies, and they're the main tool for bringing new treatments to market. But they can also have more immediate benefits for the people enrolled in a study.

Courtesy of Dr. David Maloney / Fred Hutchinson Cancer Research Center

The family of founder Jeff Bezos has given Seattle’s Fred Hutchinson Cancer Research Center its largest-ever single gift.

The $20 million donation will fund research into cancer immunotherapy, a field that uses the body’s own immune system fight tumors. Fred Hutch president Dr. Larry Corey says the line of research is making huge strides.

Seattle’s a hub for cancer research, and usually that means scientists are looking for cures or new treatments. Now a new project will try to tell us if those treatments are worth the price-tag.